- |||||||||| methamphetamine / Generic mfg.
Phase classification, Trial termination: Behavioral Therapy Development for Methamphetamine Abuse (clinicaltrials.gov) - Jan 27, 2016 P1, N=0, Terminated, Trial primary completion date: Dec 2015 --> Apr 2016 Phase classification: P=N/A --> P1 | Recruiting --> Terminated; Slow enrollment
- |||||||||| Avastin (bevacizumab) / Roche
Trial primary completion date: Autologous OC-DC Vaccine in Ovarian Cancer (clinicaltrials.gov) - Jan 25, 2016 P0, N=15, Recruiting, Trial primary completion date: Jan 2013 --> Jul 2013 Trial primary completion date: May 2015 --> May 2017
- |||||||||| Onconase (ranpirnase) / Orgenesis, Leidos
Trial initiation date, Trial primary completion date: Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) (clinicaltrials.gov) - Jan 22, 2016 P2, N=50, Not yet recruiting, Trial primary completion date: Dec 2014 --> Dec 2016 Initiation date: Oct 2015 --> Feb 2016 | Trial primary completion date: Jan 2016 --> May 2016
- |||||||||| Trial completion, Trial primary completion date: Lymph Node Counts in Endometrial Cancer Staging (clinicaltrials.gov) - Jan 21, 2016
P=N/A, N=120, Completed, Trial primary completion date: May 2016 --> May 2017 Active, not recruiting --> Completed | Trial primary completion date: Sep 2015 --> Mar 2015
- |||||||||| Trial primary completion date, HEOR, Surgery: Lymphedema in Endometrial Cancer (clinicaltrials.gov) - Jan 21, 2016
P=N/A, N=100, Recruiting, Active, not recruiting --> Completed | Trial primary completion date: Sep 2015 --> Mar 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| Trial completion, Preclinical, Trial primary completion date, Head-to-Head: Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation (clinicaltrials.gov) - Jan 20, 2016
P3, N=40, Completed, Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jan 2016
- |||||||||| Trial primary completion date: Role of Metabolomics in the Diagnosis of Endometriosis (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=40, Active, not recruiting, Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Dec 2015 --> Mar 2016
- |||||||||| Trial completion, Trial primary completion date: Perceptions of Cervical Cancer Among Asian Americans (clinicaltrials.gov) - Jan 16, 2016
P=N/A, N=52, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jan 2016
- |||||||||| Trial termination, Trial primary completion date: Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer (clinicaltrials.gov) - Jan 15, 2016
P0, N=750, Terminated, Recruiting --> Completed | N=240 --> 165 | Trial primary completion date: Jun 2014 --> Jul 2015 Active, not recruiting --> Terminated | Trial primary completion date: Aug 2015 --> Dec 2015; Closed per local IRB due to advancements in standard ovarian cancer screening.
- |||||||||| birinapant (IGM-9427) / IGM Biosciences, conatumumab (AMG 655) / Amgen
Trial completion, Enrollment change, Combination therapy: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer (clinicaltrials.gov) - Jan 15, 2016 P1, N=27, Completed, Active, not recruiting --> Terminated | Trial primary completion date: Aug 2015 --> Dec 2015; Closed per local IRB due to advancements in standard ovarian cancer screening. Active, not recruiting --> Completed | N=40 --> 27
- |||||||||| Enrollment change, Trial primary completion date: Pillars4Life Trial (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=250, Recruiting, N=48 --> 60 N=180 --> 250 | Trial primary completion date: Dec 2015 --> Jun 2016
|